MY109939A - Patches for percutaneous administration of skin- whitening materials - Google Patents
Patches for percutaneous administration of skin- whitening materialsInfo
- Publication number
- MY109939A MY109939A MYPI93000266A MYPI19930266A MY109939A MY 109939 A MY109939 A MY 109939A MY PI93000266 A MYPI93000266 A MY PI93000266A MY PI19930266 A MYPI19930266 A MY PI19930266A MY 109939 A MY109939 A MY 109939A
- Authority
- MY
- Malaysia
- Prior art keywords
- skin
- whitening
- whitening materials
- layer
- derivatives
- Prior art date
Links
- 239000000463 material Substances 0.000 title abstract 6
- 230000002087 whitening effect Effects 0.000 title 1
- 239000010410 layer Substances 0.000 abstract 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 abstract 2
- 239000012790 adhesive layer Substances 0.000 abstract 2
- 239000011241 protective layer Substances 0.000 abstract 2
- -1 BUTYLHYDROXY Chemical class 0.000 abstract 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 229960005070 ascorbic acid Drugs 0.000 abstract 1
- 235000010323 ascorbic acid Nutrition 0.000 abstract 1
- 239000011668 ascorbic acid Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000003623 enhancer Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 abstract 1
- 229960004705 kojic acid Drugs 0.000 abstract 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003573 thiols Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Abstract
A NEW FORMULATION FROM OF SKIN-WHITENING MATERIALS IS DISCLOSED. THE PRESENT INVENTION DISCLOSES PATCHES FOR PERCUTANEOUS ADMINISTRATION OF ONE OR MORE SKIN-WHITENING MATERIALS WHICH EXHIBITS TYROSINASE-INHIBITING ACTIVITY. THE PATCH MAY HAVE THE MATRIX FORM COMPOSED OF A COVERING LAYER (1) A RESERVOIR-ADHESIVE LAYER (2) CONTAINING SKIN-WHITENING MATERIALS AND PERMEATION ENHANCERS AND A DETACHABLE PROTECTIVE LAYER (6).THE PATCH ALSO MAY HAVE THE LAMINATE POUCH FORM CONSISTING OF A COVERING LAYER (1), A RESERVOIR (3) FOR SKIN-WHITENING MATERIALS, A RELEASE RATE CONTROLLING LAYER (4), AN ADHESIVE LAYER (5) AND A DETACHABLE PROTECTIVE LAYER (6). THE SKIN-WHITENING MATERIAL MAY BE SELECTED FROM THE GROUP CONSISTING OF ASCORBIC ACID AND ITS DERIVATIVES, KOJIC ACID AND ITS DERIVATIVES, GLYCOSE AMINES, HYDROQUINONE AND ITS DERIVATIVES, COMPOUNDS HAVING A THIOL GROUP, BUTYLHYDROXY TOLUENE AND BUTYLHYDROXY ANISONE. (FIG. 1 AND 2)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1019920003699A KR960006859B1 (en) | 1992-03-06 | 1992-03-06 | Improved method for stability of ageing comprising thirosinase inhibitor activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY109939A true MY109939A (en) | 1997-10-31 |
Family
ID=19330034
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI93000266A MY109939A (en) | 1992-03-06 | 1993-02-18 | Patches for percutaneous administration of skin- whitening materials |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JP2655983B2 (en) |
| KR (1) | KR960006859B1 (en) |
| CN (1) | CN1056509C (en) |
| GB (1) | GB2265086B (en) |
| MY (1) | MY109939A (en) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2706143B1 (en) | 1993-06-07 | 1995-08-11 | Oreal | Method for molding a makeup composition and makeup product obtained. |
| FR2723316B1 (en) * | 1994-08-04 | 1996-10-04 | Thorel Jean Noel | SKIN DEPIGMENTING COMPOSITIONS AND PREPARATIONS FOR PHARMACEUTICAL OR COSMETIC USES |
| WO1996008233A1 (en) * | 1994-09-14 | 1996-03-21 | Kuyus-Stiftung | Cosmetic process |
| CA2204777A1 (en) * | 1994-11-15 | 1996-05-23 | Steven Scott Porter | Skin care compositions and methods |
| FR2737116B1 (en) * | 1995-07-25 | 1997-08-22 | Oreal | STABLE COMPOSITION CONTAINING A WATER SENSITIVE COSMETIC AND / OR DERMATOLOGICAL ACTIVE |
| FR2737122B1 (en) * | 1995-07-25 | 1997-09-12 | Oreal | STABLE COMPOSITION CONTAINING ASCORBIC ACID |
| BR9612763A (en) * | 1996-11-04 | 1999-12-07 | Procter & Gamble | Cosmetic composition to lighten the skin and processes to lighten the skin and prepare that composition |
| JPH11116435A (en) * | 1997-10-06 | 1999-04-27 | Nitto Denko Corp | Whitening cosmetic sheet and method of using the same |
| US6623751B2 (en) | 1998-07-30 | 2003-09-23 | L'oreal S.A. | Cosmetic, pharmaceutical, or dermatological patch |
| DE19911262C2 (en) * | 1999-03-13 | 2003-04-10 | Scs Skin Care Systems Gmbh | Device for dispensing cosmetic active ingredients |
| KR100535261B1 (en) * | 1999-03-29 | 2005-12-09 | 주식회사 태평양 | A cosmetic having hydrogel matrix adsheive sheet type |
| EP1210077A4 (en) * | 1999-06-15 | 2002-12-18 | Benjamin D Gordon | Compositions and systems for the treatment of hyperpigmentation |
| US6458379B1 (en) * | 1999-10-15 | 2002-10-01 | Nitto Denko Corporation | Sheet for whitening cosmetics and method for using the same |
| FR2805720B1 (en) | 2000-03-03 | 2002-08-16 | Oreal | DEVICE INCLUDING AN APPLICATOR AND / OR A MAGNETIC SPINNER |
| US7658942B2 (en) | 2000-04-12 | 2010-02-09 | The Procter & Gamble Company | Cosmetic devices |
| CA2382142C (en) | 2000-07-12 | 2005-08-23 | L'oreal | Device for packaging and/or applying a product containing fibres comprising at least a magnetised or magnetizable element |
| AU2001276883B2 (en) * | 2000-07-13 | 2004-05-13 | Skinmedica, Inc. | Composition for topically delivering vitamin c |
| DE10054479A1 (en) * | 2000-11-03 | 2002-05-08 | Henkel Kgaa | Cosmetic plasters for skin lightening |
| JP2004517109A (en) * | 2000-12-30 | 2004-06-10 | エルジー ハウスホールド アンド ヘルスケア カンパニー., リミテッド. | A skin lightening agent containing a glucose-acylated derivative or a sucrose-acylated derivative {Cosmeticforskinwhiteningcontainingacylsubstitutedderivativesofglucoseorsucrose} |
| JP3763567B2 (en) * | 2001-01-19 | 2006-04-05 | 株式会社資生堂 | Cosmetics |
| FR2822711B1 (en) | 2001-03-28 | 2003-06-13 | Oreal | TREATMENT DEVICE COMPRISING AN ENVELOPE DEFINING A CAVITY IN WHICH A PART OF THE BODY MAY BE ENGAGED |
| JP2002293714A (en) * | 2001-03-30 | 2002-10-09 | Fancl Corp | Skin cosmetics |
| US7189759B2 (en) | 2001-05-23 | 2007-03-13 | Medicis Pharmaceutical Corporation | Compositions for the treatment of pigmentation disorders and methods for their manufacture |
| JP2003048832A (en) * | 2001-08-02 | 2003-02-21 | Kosumedei:Kk | Patch for skin conditioning |
| ITMI20020509A1 (en) * | 2002-03-11 | 2003-09-11 | Carlo Ghisalberti | COSMETIC DEPIGMENTANT COMPOSITIONS |
| KR20030082765A (en) * | 2002-04-18 | 2003-10-23 | 한국화학연구원 | Transdermal drug delivery matrix type system contained hydroquinone and cosmetic ingredients |
| CN100496453C (en) * | 2003-07-10 | 2009-06-10 | 株式会社高丝 | Powdery compositions and skin preparation containing the same for external use |
| JP2007119405A (en) * | 2005-10-28 | 2007-05-17 | Sansho Kaken Kk | Skin care plaster |
| US8410171B2 (en) | 2006-10-26 | 2013-04-02 | Ono Pharmaceutical Co., Ltd. | Adhesive preparation |
| US20080147022A1 (en) * | 2006-12-15 | 2008-06-19 | Kimberly-Clark Worldwide, Inc. | Skin care delivery device having a releasable backing |
| JP2011173851A (en) * | 2010-02-25 | 2011-09-08 | Kazki International:Kk | Patch for beautification |
| DE102013204070A1 (en) * | 2013-03-11 | 2014-09-11 | Beiersdorf Ag | Use of cosmetically or dermatologically acceptable substituted Michael acceptors for the prevention, reduction or prophylaxis of the tyrosinase activity of the human skin and / or its lightening |
| JP6212320B2 (en) * | 2013-08-01 | 2017-10-11 | ポーラ化成工業株式会社 | Topical skin preparation |
| KR102908604B1 (en) * | 2022-01-27 | 2026-01-08 | 국립금오공과대학교 산학협력단 | Spot-patch for Freckle treatment using Hydroquinone and Manufacturing method thereof |
| CN114712334A (en) * | 2022-04-08 | 2022-07-08 | 季华实验室 | A kind of traumatic oil gel patch and preparation method thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6078912A (en) * | 1983-10-06 | 1985-05-04 | Shiseido Co Ltd | Cosmetic |
| DE3409079A1 (en) * | 1984-03-13 | 1985-09-19 | Bayer Ag, 5090 Leverkusen | MEDICAL PLASTER |
| JPS61194008A (en) * | 1985-02-25 | 1986-08-28 | Shiseido Co Ltd | Cosmetic |
| US4615699A (en) * | 1985-05-03 | 1986-10-07 | Alza Corporation | Transdermal delivery system for delivering nitroglycerin at high transdermal fluxes |
| US4698062A (en) * | 1985-10-30 | 1987-10-06 | Alza Corporation | Medical device for pulsatile transdermal delivery of biologically active agents |
| JPS62153214A (en) * | 1985-12-26 | 1987-07-08 | Nitto Electric Ind Co Ltd | Pharmaceutical preparation |
| JPS62169723A (en) * | 1986-01-22 | 1987-07-25 | Teisan Seiyaku Kk | Sustained release preparation |
| JP2540581B2 (en) * | 1988-02-04 | 1996-10-02 | 三省製薬株式会社 | Topical |
| JPH02149514A (en) * | 1988-04-06 | 1990-06-08 | Nitto Denko Corp | Material for medicine |
| JPH0278616A (en) * | 1988-09-14 | 1990-03-19 | Sekisui Chem Co Ltd | Plaster |
-
1992
- 1992-03-06 KR KR1019920003699A patent/KR960006859B1/en not_active Expired - Fee Related
-
1993
- 1993-02-18 MY MYPI93000266A patent/MY109939A/en unknown
- 1993-03-04 JP JP5044136A patent/JP2655983B2/en not_active Expired - Fee Related
- 1993-03-05 GB GB9304519A patent/GB2265086B/en not_active Expired - Fee Related
- 1993-03-06 CN CN93102465A patent/CN1056509C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| KR930019201A (en) | 1993-10-18 |
| JP2655983B2 (en) | 1997-09-24 |
| GB2265086A (en) | 1993-09-22 |
| GB9304519D0 (en) | 1993-04-21 |
| JPH07258060A (en) | 1995-10-09 |
| GB2265086B (en) | 1996-03-06 |
| KR960006859B1 (en) | 1996-05-23 |
| CN1056509C (en) | 2000-09-20 |
| CN1076110A (en) | 1993-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY109939A (en) | Patches for percutaneous administration of skin- whitening materials | |
| CA2153572A1 (en) | Transdermal therapeutic system with galanthamine as active ingredient | |
| AU635021B2 (en) | Extended release pharmaceutical formulations | |
| PL311590A1 (en) | Estradiol containing percutaneous therapeutic system | |
| AU4877090A (en) | Therapeutic system for the retarded and controlled transdermal or transmucous administration of active substances | |
| AU579970B2 (en) | Self-adhesive plaster containing medication | |
| AU632182B2 (en) | Transdermal therapeutic system comprising as active component buprenorphine | |
| AU4304685A (en) | Medicinal self-adhesive plaster | |
| ZA977832B (en) | Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents. | |
| NO962933L (en) | Ostradiol penetration enhancer for transdermal administration | |
| MY110531A (en) | Plaster for the transdermal application of steroid hormones, containing dexpanthenol | |
| CA2148112A1 (en) | New pharmaeutical dosage form for transdermal administration | |
| AU4684389A (en) | Transdermal therapeutic system comprising norpseudoephedrine as active component | |
| MD937B2 (en) | ||
| AU6879887A (en) | Dermal and transdermal patches having a discontinuous pattern adhesive layer | |
| WO1997009050A3 (en) | Tacrine patch |